Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance
Ting‐Wan Kao, Geng-Hao Bai, Tian‐Li Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer
Saba Musleh Ud Din, S. Streit, Bao Tran Huynh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2060-2060
Open Access | Times Cited: 17
Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities
Claire Beckers, Martin Pruschy, Irene Vetrugno
Seminars in Cancer Biology (2023) Vol. 98, pp. 19-30
Open Access | Times Cited: 30
Polyphyllin I ameliorates gefitinib resistance and inhibits the VEGF/VEGFR2/p38 pathway by targeting HIF-1a in lung adenocarcinoma
Dengtian Zhang, Xinchen Tian, Youzhi Wang, et al.
Phytomedicine (2024) Vol. 129, pp. 155690-155690
Closed Access | Times Cited: 7
Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer
Khaled Elsayad, Ghada F. Elmasry, Sally Tarek Mahmoud, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107409-107409
Closed Access | Times Cited: 5
Impact of HIF-1α, LOX and ITGA5 Synergistic Interaction in the Tumor Microenvironment on Colorectal Cancer Prognosis
Hayriye Tatlı Doğan, Mehmet Doğan, Seda Kahraman, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 184-184
Open Access
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access
Exploring the Role of Hypoxia and HIF-1α in the Intersection of Type 2 Diabetes Mellitus and Endometrial Cancer
A Geetha, Kannan Harithpriya, Kumar Ganesan, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 106-106
Open Access
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Jennifer Haynes, Prasath Manogaran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1988-1988
Open Access
Oncolytic polymer-mediated combretastatin A4 phosphate delivery for enhancing vascular disrupting therapy
Huihui Li, Kang Liu, Zexin Yang, et al.
International Journal of Pharmaceutics (2025), pp. 125438-125438
Closed Access
Decoding Metabolic Changes in Cancer Cells Resistant to Therapy
Shehzeen Noor, Shaukat Ali, Muhammad Summer, et al.
Interdisciplinary cancer research (2025)
Closed Access
Polydopamine-armed microalgal oxygenerator targeting the hypoxia-adenosine axis to boost cancer photothermal immunotherapy
Cheng Zhang, Ziyi Han, Kewei Chen, et al.
Materials Today (2024) Vol. 75, pp. 71-84
Closed Access | Times Cited: 4
Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy
Concetta Meo, Filomena de Nigris
Cancers (2024) Vol. 16, Iss. 3, pp. 491-491
Open Access | Times Cited: 3
Tumor Microenvironment: Cellular Interaction and Metabolic Adaptations
Monica Benvenuto, Chiara Focaccetti
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3642-3642
Open Access | Times Cited: 3
Hypoxia‐mediated attenuation of EGLN2 inhibition of the NF‐κB signaling pathway leads to the formation of a loop between HIF‐1α and MUC1‐C promoting chemoresistance in bladder cancer
Liangliang Qing, Qingchao Li, Yongjin Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1303-1318
Closed Access | Times Cited: 3
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells
Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1729-1729
Open Access | Times Cited: 3
Non-oncogene dependencies: Novel opportunities for cancer therapy
Tiziana Di Marco, Mara Mazzoni, Angela Greco, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116254-116254
Closed Access | Times Cited: 3
Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment
Chuansheng Yang, Xinpei Deng, Yunyun Tang, et al.
Cancer Letters (2024) Vol. 598, pp. 217116-217116
Closed Access | Times Cited: 3
Hypoxic tumor microenvironment: Destroyer of natural killer cell function
Yongfei Zhang, Feifei Guo, Yufeng Wang
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 138-150
Open Access | Times Cited: 2
Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma
Masaki Uchihara, Akiyo Tanabe, Yuki Kojima, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2191-2191
Open Access | Times Cited: 2
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS -Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial
Daniel H. Ahn, Maya Ridinger, Timothy Lewis Cannon, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 2
Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?
Tsu‐Kung Lin, Chi-Ren Huang, Kai-Jung Lin, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1378-1378
Open Access | Times Cited: 2
Bacterial therapy: a promising strategy for cancer immunotherapy
Yinsong Wang
Cancer Biology and Medicine (2023), pp. 1-4
Open Access | Times Cited: 5
Hypoxic Effects on Matrix Metalloproteinases’ Expression in the Tumor Microenvironment and Therapeutic Perspectives
Georgina González-Ávila, Bettina Sommer, Edgar Flores‐Soto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16887-16887
Open Access | Times Cited: 5
Role of natural secondary metabolites as HIF-1 inhibitors in cancer therapy
Prem Shankar Mishra, Rakhi Mishra, Vaishali M. Patil, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 5, pp. 721-734
Closed Access | Times Cited: 1
An agent-based modelling framework for tumour growth incorporating mechanical and evolutionary aspects of cell dynamics
Cicely K. Macnamara, Ignacio Ramis-Conde, Tommaso Lorenzi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top